Changes in the secretion of insulin-like growth factor binding proteins-2 and-4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines
P. Maxwell et Hw. Van Den Berg, Changes in the secretion of insulin-like growth factor binding proteins-2 and-4 associated with the development of tamoxifen resistance and estrogen independence in human breast cancer cell lines, CANCER LETT, 139(2), 1999, pp. 121-127
We investigated the secretion of insulin-like growth factor binding protein
s (IGFBPs) by estrogen-dependent ZR-75-1 and MCF-7 human breast cancer cell
s, and tamoxifen-resistant (ZR-75-9al and LY2) and estrogen-independent (ZR
-PR-LT) variants which express altered levels of IGF-I receptor. IGFBP spec
ies (35 kDa and 44 kDa) were detectable in conditioned serum-free medium (S
FM) by immunoblotting and positively identified as IGFBP-2 and -3, respecti
vely. Secretion of IGFBP-2 into SFM by the tamoxifen-resistant and estrogen
-independent cell lines was markedly reduced and secretion into SFM of the
24-kDa species, assigned the identity of IGFBP-4, was also reduced in the t
amoxifen-resistant lines. There was no clear correlation between patterns o
f IGFBP secretion and IGF-I receptor expression. (C) 1999 Elsevier Science
Ireland Ltd. All rights reserved.